The Behavior of Tendon Progenitor Cells from Tendinopathic Tendons: Implications for Treatment.

A new interesting article has been published in Tissue Eng Part A. 2019 May 21. doi: 10.1089/ten.TEA.2019.0042. and titled:

The Behavior of Tendon Progenitor Cells from Tendinopathic Tendons: Implications for Treatment.

Authors of this article are:

Chang W, Callan KT, Dragoo JL.

A summary of the article is shown below:

Tendinopathy remains a significant clinical challenge. Although there is some evidence that Leukocyte-Rich PRP can improve the symptoms of tendinopathy, more efficacious treatments will be required in the future to improve probability of successfully resolving this condition in athletes. Because optimal treatments are not currently available, there is a need to better understand the pathology of tendinopathy from the perspective of tendon progenitor cells (TPCs). TPCs isolated from normal and tendinopathy donors were characterized by their stem cell properties and proliferation capacities, along with their ability to become tenocytes under mechanical loading. The results showed a significant 2.6-fold increase in the viable cell population in tendinopathy versus normal donors. Although the percentage of self-renewing cells was similar, the total number of TPCs in tendinopathy was significantly higher (1.6-fold) than normal TPCs based on the colony formation assays. In contrast, TPCs from tendinopathy tissue showed significantly lower cellular proliferation rate by cumulative population doublings. Next, the expanded TPCs from both tissues successfully demonstrated the trilineage differentiation capabilities with specific gene markers, staining, and biochemical assays. To induce tenogenic differentiation, stretchable silicone wells were designed and fabricated, plus the creation of an adaptor platform used on a syringe pump for mechanical stretch. This economic design provided the adequate cyclic loading to drive tenogenic differentiation. With these devices, the stretch duration was optimized and showed the significant increase in scleraxis (SCX) and tenomodulin (TNMD) expression at 2.60 (fold change) and 3.86 (fold change in logarithm) respectively by RT-qPCR in normal TPCs after stretch. This assay also demonstrated the wide spread cell re-orientation following stretch in normal TPCs. In contrast, the mechanical loading didn’t increase the SCX gene expression; TNMD expression remained undetectable, and cell re-alignment was significantly less in tendinopathy TPCs. Additionally, western blot analysis confirmed the elevated TNMD protein expression in normal TPCs following stretch and the lack of expression in tendinopathy TPCs. In summary, tendinopathy TPCs were unable to differentiate into tenocytes following mechanical stretch. Future studies may aim to reprogram tendinopathy TPCs to allow tenogenic induction.

Check out the article’s website on Pubmed for more information:

This article is a good source of information and a good way to become familiar with topics such as: n/a.

Molecular Depot

Your specialty peptide, proteins, antibodies and chemical compounds store.